Michael Barbella, Managing Editor07.12.23
AdaptHealth Corp. has a new leader.
The company's Board of Directors has named Crispin Teufel as CEO, succeeding former chief executive Stephen Griggs, who steppted down from the position on June 30. Teufel is expected to assume the role on Sept. 1. Board Chairman Richard Barasch is now serving as interim CEO until Teufel begins his tenure.
“We are quite pleased to be announcing the appointment of Crispin Teufel as the next chief executive officer of AdaptHealth,” Barasch said. “Crispin is the ideal candidate to lead AdaptHealth in its mission to transform care by keeping patients healthy in their homes. We are fortunate to have found such an experienced executive with deep industry understanding and a proven track record of success. The board and I are confident that he will lead this organization to future success.”
Teufel, 47, has served as CEO of Lincare Holdings Inc., a national provider of in-home respiratory care with more than 700 locations in 48 states, since July 2017. Previously, Teufel was chief financial officer of Lincare from 2013 to 2019 and a finance director for Linde Engineering in Germany from 2011 to 2013. Prior to joining Linde in 2005, Teufel began his career with financial roles at PWC and Arthur Andersen. Teufel currently serves on the Board of Directors of Bellerophon Therapeutics, a clinical-stage biotherapeutics company, and as board chairman of the German American Chamber of Commerce of the South.
Teufel earned an MBA in economics from Ruhr University Bochum, Germany, is a certified public accountant, and a German tax advisor.
“AdaptHealth has established itself as a leader in the industry and I am honored to be assuming the role of CEO at this pivotal time as the company enters the next era of at-home care. Together with the entire Adapt team and Board of Directors, I look forward to leveraging my expertise in the space to foster innovation and deliver value to the company’s customers and stakeholders,” Teufel stated.
AdaptHealth provides patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services); devices and supplies for diabetes treatment (including continuous glucose monitors and insulin pumps); HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company partners with an extensive network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching more than 3.9 million patients annually in all 50 states.
The company's Board of Directors has named Crispin Teufel as CEO, succeeding former chief executive Stephen Griggs, who steppted down from the position on June 30. Teufel is expected to assume the role on Sept. 1. Board Chairman Richard Barasch is now serving as interim CEO until Teufel begins his tenure.
“We are quite pleased to be announcing the appointment of Crispin Teufel as the next chief executive officer of AdaptHealth,” Barasch said. “Crispin is the ideal candidate to lead AdaptHealth in its mission to transform care by keeping patients healthy in their homes. We are fortunate to have found such an experienced executive with deep industry understanding and a proven track record of success. The board and I are confident that he will lead this organization to future success.”
Teufel, 47, has served as CEO of Lincare Holdings Inc., a national provider of in-home respiratory care with more than 700 locations in 48 states, since July 2017. Previously, Teufel was chief financial officer of Lincare from 2013 to 2019 and a finance director for Linde Engineering in Germany from 2011 to 2013. Prior to joining Linde in 2005, Teufel began his career with financial roles at PWC and Arthur Andersen. Teufel currently serves on the Board of Directors of Bellerophon Therapeutics, a clinical-stage biotherapeutics company, and as board chairman of the German American Chamber of Commerce of the South.
Teufel earned an MBA in economics from Ruhr University Bochum, Germany, is a certified public accountant, and a German tax advisor.
“AdaptHealth has established itself as a leader in the industry and I am honored to be assuming the role of CEO at this pivotal time as the company enters the next era of at-home care. Together with the entire Adapt team and Board of Directors, I look forward to leveraging my expertise in the space to foster innovation and deliver value to the company’s customers and stakeholders,” Teufel stated.
AdaptHealth provides patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services); devices and supplies for diabetes treatment (including continuous glucose monitors and insulin pumps); HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company partners with an extensive network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching more than 3.9 million patients annually in all 50 states.